View Older Stories View More Recent Stories

Jul 1, 2022 09:20AM Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering
Jul 1, 2022 09:20AM Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering
Apr 7, 2022 07:30AM Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)
Apr 7, 2022 07:30AM Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)
Mar 14, 2022 08:00AM Agile Therapeutics (AGRX) Announces 24.25M Share and Warrant Offering at $0.20/sh
Mar 14, 2022 08:00AM Agile Therapeutics Announces $4.85 Million Registered Direct Offering
Mar 14, 2022 08:00AM Agile Therapeutics Announces $4.85 Million Registered Direct Offering
Oct 8, 2021 08:30AM Agile Therapeutics (AGRX) Prices 26.67M Share and Warrant Offering at $0.85/sh
Oct 8, 2021 08:30AM Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants
Oct 8, 2021 08:30AM Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants
Oct 7, 2021 04:05PM Agile Therapeutics (AGRX) Announces Proposed Stock Offering, Size not Disclosed
Oct 7, 2021 04:05PM Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
Oct 7, 2021 04:05PM Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
Feb 19, 2021 08:35AM Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Feb 19, 2021 08:35AM Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Jan 4, 2021 12:18PM Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Jan 4, 2021 12:18PM Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Dec 21, 2020 07:30AM Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 21, 2020 07:30AM Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Nov 30, 2020 09:13AM Agile Therapeutics (AGRX) Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla Transdermal System in Contraception
Nov 30, 2020 09:11AM Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception
Nov 30, 2020 09:11AM Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception
Nov 23, 2020 10:00AM Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
Nov 23, 2020 10:00AM Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
Nov 4, 2020 07:30AM Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial Updates on Thursday, November 12, 2020
Nov 4, 2020 07:30AM Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial Updates on Thursday, November 12, 2020
Sep 22, 2020 11:40AM Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 22, 2020 11:40AM Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 9, 2020 08:00AM Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference
Sep 9, 2020 08:00AM Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference
Sep 8, 2020 08:00AM Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020
Sep 8, 2020 08:00AM Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020
Sep 2, 2020 09:00AM Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control
Sep 2, 2020 09:00AM Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control
Aug 17, 2020 08:00AM Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer
Aug 17, 2020 08:00AM Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer
Aug 11, 2020 04:02PM Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
Aug 11, 2020 04:02PM Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
Jul 21, 2020 07:30AM Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020
Jul 21, 2020 07:30AM Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020
Jun 16, 2020 08:00AM Agile Therapeutics to Join Russell 3000® and 2000® Indexes
Jun 16, 2020 08:00AM Agile Therapeutics to Join Russell 3000® and 2000® Indexes
May 11, 2020 04:05PM Agile Therapeutics to Participate in Virtual Fireside Chat as part of the 2020 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2020
May 11, 2020 04:05PM Agile Therapeutics to Participate in Virtual Fireside Chat as part of the 2020 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2020
Apr 23, 2020 07:30AM Agile Therapeutics to Host First Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, May 5, 2020
Apr 23, 2020 07:30AM Agile Therapeutics to Host First Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, May 5, 2020
Apr 22, 2020 08:00AM Agile Therapeutics Announces Changes to its Board of Directors
Apr 22, 2020 08:00AM Agile Therapeutics Announces Changes to its Board of Directors
Feb 25, 2020 11:41AM Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020
Feb 25, 2020 11:41AM Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020
View More Recent Stories View Older Stories